AUG 30, 2022 9:57 AM PDT

Caffeine Metabolite Could Slow Progression of Nearsightedness in Children

WRITTEN BY: Zoe Michaud

Myopia, also known as nearsightedness, is a common vision condition in which objects far away appear blurry. Myopia occurs when the shape of your eye causes light rays to refract incorrectly, resulting in out of focus images. 

Nearsightedness often begins in childhood and adolescence. It typically occurs first around the age of 6 and worsens into the late teenage years. Myopia tends to run in families and is also associated with a heightened risk of various eye conditions later in life, including macular degeneration, cataracts, glaucoma and retinal detachment.

7-Methylxanthine (also known as 7-MX) is a metabolite of caffeine. It acts as an adenosine receptor (AR) antagonist and has been used to treat childhood myopia in children in Denmark since 2009. Given the success of using 7-MX as a treatment in Denmark, researchers are calling for large clinical trials to prove the safety of efficacy of 7-MX, which would allow it to be used as a treatment option for myopia. 

It is thought that 7-MX works by inhibiting the excessive lengthening of the eye that causes myopia. In a recent study, researchers reviewed the medical records of 711 children who were treated for myopia in Denmark. Of the group of children, 624 took 7-MX tablets daily as part of their treatment. 

The researchers found that 7-MX treatment was associated with a slower rate of worsening myopia and lengthening of the eye. They found that, without treatment, a child’s axial length would increase by 1.80 mm over 6 years. With treatment, the axial length only increased by 1.63 mm. Higher doses of 7-MX seemed to be more effective and no negative effects of the treatment were reported. 

Since this is an observational study, it cannot be determined that 7-MX was the cause of improvements in eye health. The researchers noted that “ 7-MX may become a valuable supplement if causality and efficacy can be confirmed in future randomized controlled trials.”

Sources: MayoClinic, Ophthalmic Research, British Journal of Ophthalmology

 

About the Author
Biology
Zoe (she/her) is a science writer and a scientist working in genomics. She received her B.S. from the University of Connecticut with a focus in Evolutionary Biology. At Labroots, she focuses on writing scientific content related to clinical research and diagnostics.
You May Also Like
OCT 17, 2022
Genetics & Genomics
Genetic Markers Can Differentiate Between ADHD & Autism
OCT 17, 2022
Genetic Markers Can Differentiate Between ADHD & Autism
The symptoms of attention deficit/hyperactivity disorder (ADHD) and autism have many things in common; they are both com ...
OCT 25, 2022
Cancer
Study Identifies Patients at High Risk of Breast Cancer Metastasis
OCT 25, 2022
Study Identifies Patients at High Risk of Breast Cancer Metastasis
Central nervous system metastasis (mCNS) accounts for most brain and spinal cord tumors.  While recent advances hav ...
NOV 03, 2022
Cardiology
Time-restricted Eating Improves Cardiovascular Health in Firefighters
NOV 03, 2022
Time-restricted Eating Improves Cardiovascular Health in Firefighters
Reducing eating time to a 10-hour window improves quality of life and health measures.
NOV 11, 2022
Cancer
Veterans and Burn Pit Exposure
NOV 11, 2022
Veterans and Burn Pit Exposure
Today we recognize the Veterans Day holiday in the United States.  Each year, on November 11, Americans commemorate ...
NOV 22, 2022
Technology
Specialized MRI Shows Post-COVID Brain Changes
NOV 22, 2022
Specialized MRI Shows Post-COVID Brain Changes
Since the start of the pandemic, researchers have learned a lot about the health effects of COVID-19 infection. In parti ...
DEC 01, 2022
Cardiology
Black Tea Improves Health Later in Life
DEC 01, 2022
Black Tea Improves Health Later in Life
Tea and other foods containing flavonoids appear to protect against vascular disease events.
Loading Comments...